Skip to main content
Clinical Trials/ACTRN12610000743066
ACTRN12610000743066
Completed
Phase 2

In coronary artery bypass patients requiring greater than 2 lengths of saphenous vein for conduit does the application of a cyanoacrylate surgical sealant prior to leg wound incision decrease wound infection rates scored at 1 monthwhen compared to the contralateral leg wound in the same patient.

Ian Gilfillan0 sites100 target enrollmentSeptember 7, 2010

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Surgical Site Infection
Sponsor
Ian Gilfillan
Enrollment
100
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 7, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ian Gilfillan

Eligibility Criteria

Inclusion Criteria

  • Isolated Coronary Artery bypass patients requiring greater than 2 lengths of saphenous vein conduit.

Exclusion Criteria

  • Peripheral vascular disease, long saphenous vein abnormality, leg skin lesions or ulcers, prior sensitivity to cyanoacrlate, acetone or formaldehyde containg products, non consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials